311690 — CJ Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for CJ Bioscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	31,046	39,255	80,060	49,308	64,095
Net Total Accounts Receivable
Net Total Receivables	214	409	721	1,025	540
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31,642	41,089	81,555	50,932	65,210
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,728	19,991	9,856	14,364	12,707
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	33,741	73,362	116,355	91,389	91,128
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,305	3,004	23,836	34,979	14,722
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	2,887	38,878	28,502	41,734	19,633
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	30,855	34,484	87,853	49,655	71,496
Total Liabilities & Shareholders' Equity	33,741	73,362	116,355	91,389	91,128
Total Common Shares Outstanding